bf/NASDAQ:NBIX_icon.jpeg

COM:NEUROCRINE

Neurocrine Biosciences

  • Stock

USD

Last Close

125.00

22/11 21:00

Market Cap

13.71B

Beta: -

Volume Today

1.18M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-7.06M
-
-11.50K
99.84%
-15.56M
-
-10.13M
34.90%
14.08M
238.93%
22.64M
60.87%
29.25M
29.17%
32.80M
12.14%
36.70M
11.89%
average payables
506K
-
173.50K
65.71%
1.40M
708.93%
3.82M
172.39%
5.37M
40.37%
9.72M
81.21%
30.01M
208.58%
42.81M
42.65%
45.45M
6.17%
63.90M
40.59%
38.15M
40.30%
average receivables
7.06M
-
11.50K
99.84%
15.56M
-
43.68M
180.68%
91.41M
109.25%
141.84M
55.17%
171.30M
20.77%
267.75M
56.30%
394.65M
47.39%
book value per share
1.80
-
2.80
55.69%
5.02
79.51%
3.63
27.71%
4.22
16.34%
5.33
26.17%
6.95
30.45%
12.10
73.98%
14.52
20.07%
17.83
22.74%
22.85
28.15%
capex per share
-0.01
-
-0.02
165.69%
-0.02
5.89%
-0.05
106.98%
-0.08
66.30%
-0.28
249.15%
-0.16
41.47%
-0.12
27.28%
-0.25
111.27%
-0.17
30.37%
-0.29
68.18%
capex to depreciation
-0.81
-
-1.95
139.99%
-1.92
1.67%
-2.83
47.50%
-2.89
2.28%
-6.17
113.23%
-1.98
67.90%
-1.27
35.96%
-2.15
69.38%
-1.06
50.73%
56.60
5,451.27%
capex to operating cash flow
0.02
-
0.03
85.77%
0.05
48.84%
0.04
23.99%
0.07
90.16%
-0.24
432.72%
-0.10
60.38%
-0.05
50.82%
-0.09
91.24%
-0.05
46.71%
-0.07
49.30%
capex to revenue
-0.19
-
-0.10
-
-0.27
179.94%
-0.04
84.32%
-0.05
28.06%
-0.02
65.97%
-0.01
44.31%
-0.02
98.09%
-0.01
46.31%
-0.01
35.31%
cash per share
2.18
-
2.60
19.45%
4.49
72.68%
3.54
21.02%
5.86
65.24%
7.22
23.21%
7.32
1.44%
15.20
107.61%
7.52
50.53%
10.33
37.34%
10.56
2.25%
days of inventory on hand
-9.06K
-
811.08
108.95%
852.72
5.13%
1.01K
18.67%
778.50
23.06%
552.22
29.07%
352.13
36.23%
days payables outstanding
1.64K
-
1.03K
37.33%
2.28K
121.23%
1.42K
37.54%
1.31K
7.68%
1.20K
8.68%
days sales outstanding
2.88
-
70.29
-
45.49
35.28%
58.62
28.86%
54.83
6.48%
59.73
8.95%
85.81
43.66%
84.97
0.98%
debt to assets
0.03
-
0.04
54.68%
0.50
1,125.83%
0.45
9.03%
0.38
16.42%
0.24
37.35%
0.21
10.59%
0.11
47.77%
0.13
18.71%
debt to equity
0.03
-
0.05
60.34%
1.10
2,222.79%
0.94
14.46%
0.78
17.04%
0.37
52.94%
0.32
12.45%
0.15
51.97%
0.19
24.68%
dividend yield
earnings yield
-0.07
-
-0.04
50.67%
-0.02
48.80%
-0.04
125.99%
-0.02
50.40%
0.00
115.72%
0.00
14.66%
0.05
1,114.60%
0.01
75.64%
0.01
21.42%
0.02
43.66%
enterprise value
580.89M
-
1.64B
181.47%
4.71B
187.81%
3.27B
30.46%
6.95B
112.37%
6.69B
3.77%
10.23B
52.95%
8.53B
16.56%
8.16B
4.43%
11.44B
40.28%
13.05B
14.05%
enterprise value over ebitda
-10.91
-
-23.95
119.57%
-47.31
97.52%
-21.30
54.98%
-52.90
148.35%
181.27
442.68%
45.14
75.10%
26.06
42.27%
39.25
50.62%
45.95
17.07%
52.01
13.19%
ev to operating cash flow
-19.62
-
-34.68
76.78%
-123.85
257.06%
-30.82
75.11%
-73.67
139.04%
65.98
189.56%
67.27
1.96%
37.35
44.48%
31.80
14.86%
33.71
6.02%
33.47
0.72%
ev to sales
199.00
-
238.04
-
218.17
8.35%
43.00
80.29%
14.82
65.53%
12.98
12.43%
8.16
37.13%
7.20
11.82%
7.69
6.81%
6.92
10.03%
free cash flow per share
-0.45
-
-0.65
45.24%
-0.47
27.71%
-1.27
169.14%
-1.15
9.61%
0.85
173.82%
1.50
76.62%
2.34
55.92%
2.46
5.42%
3.37
36.79%
3.70
9.81%
free cash flow yield
-0.05
-
-0.03
39.28%
-0.01
71.45%
-0.03
293.41%
-0.01
54.92%
0.01
180.21%
0.01
17.34%
0.02
74.86%
0.03
18.64%
0.03
2.46%
0.03
0.46%
graham net net
1.66
-
2.14
28.50%
3.89
82.01%
2.97
23.81%
0.89
70.04%
2.06
132.29%
1.15
44.45%
10.08
779.16%
1.77
82.46%
6.35
259.40%
3.69
41.85%
graham number
5.27
-
7.15
35.54%
10.91
52.55%
11.53
5.71%
12.40
7.56%
5.30
57.28%
7.95
50.05%
34.51
334.08%
17.59
49.02%
25.43
44.56%
36.25
42.51%
income quality
0.64
-
0.78
21.21%
0.43
45.13%
0.75
76.13%
0.66
12.07%
4.80
625.54%
4.11
14.44%
0.56
86.34%
2.86
410.28%
2.20
23.26%
1.56
28.92%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0.02
Infinity%
0.01
30.48%
interest coverage
-6.73
-
1.21
117.96%
6.85
466.69%
9.72
41.97%
7.63
21.50%
35.07
359.53%
-54.54
255.53%
interest debt per share
0.15
-
0.17
15.90%
4.85
2,731.62%
5.34
9.96%
5.76
7.91%
4.78
16.98%
4.93
3.08%
2.82
42.81%
4.34
53.91%
inventory turnover
-0.04
-
0.45
1,217.04%
0.43
4.88%
0.36
15.73%
0.47
29.98%
0.66
40.98%
1.04
56.82%
invested capital
0.03
-
0.05
60.34%
1.10
2,222.79%
0.94
14.46%
0.78
17.04%
0.37
52.94%
0.32
12.45%
0.15
51.97%
0.19
24.68%
market cap
625.68M
-
1.67B
166.28%
4.78B
186.90%
3.36B
29.79%
6.83B
103.67%
6.44B
5.76%
9.85B
52.86%
8.92B
9.37%
8.06B
9.71%
11.44B
42.02%
12.87B
12.50%
net current asset value
114.20M
-
163.87M
43.50%
333.74M
103.66%
260.23M
22.03%
109.47M
57.94%
225.39M
105.90%
161.90M
28.17%
407.70M
151.82%
274.30M
32.72%
792.60M
188.95%
587.60M
25.86%
net debt to ebitda
0.84
-
0.45
45.98%
0.75
64.18%
0.54
27.35%
-0.87
261.38%
6.69
864.78%
1.69
74.72%
-1.19
170.18%
0.48
140.38%
0.71
-
net income per share
-0.69
-
-0.81
17.99%
-1.05
29.64%
-1.63
54.60%
-1.62
0.55%
0.23
114.46%
0.40
72.59%
4.37
983.07%
0.95
78.35%
1.61
70.27%
2.56
58.48%
operating cash flow per share
-0.44
-
-0.63
43.02%
-0.45
28.86%
-1.22
172.30%
-1.07
12.55%
1.12
204.94%
1.66
47.72%
2.45
47.85%
2.71
10.47%
3.54
30.66%
3.99
12.65%
payables turnover
0.22
-
0.35
59.55%
0.16
54.80%
0.26
60.09%
0.28
8.32%
0.30
9.51%
receivables turnover
126.91
-
5.19
-
8.02
54.52%
6.23
22.40%
6.66
6.93%
6.11
8.22%
4.25
30.39%
4.30
0.99%
research and ddevelopement to revenue
13.45
-
4.12
-
6.29
52.49%
0.75
88.01%
0.36
52.80%
0.25
28.66%
0.26
3.61%
0.29
10.09%
0.31
7.63%
0.30
3.90%
return on tangible assets
-0.30
-
-0.25
16.40%
-0.19
24.81%
-0.39
106.33%
-0.17
54.89%
0.02
112.19%
0.03
33.28%
0.23
728.77%
0.04
81.59%
0.07
53.28%
0.08
17.17%
revenue per share
0.04
-
0.23
-
0.17
26.06%
1.83
960.68%
5.00
172.65%
8.60
71.98%
11.23
30.57%
11.98
6.66%
15.54
29.69%
19.32
24.30%
roe
-0.38
-
-0.29
24.21%
-0.21
27.78%
-0.45
113.87%
-0.38
14.52%
0.04
111.46%
0.06
32.30%
0.36
522.54%
0.07
81.97%
0.09
38.73%
0.11
23.66%
roic
-0.37
-
-0.28
23.98%
-0.20
29.64%
-0.42
110.83%
-0.19
55.36%
0.04
120.30%
0.14
273.66%
0.75
421.19%
0.09
87.84%
0.09
3.86%
0.06
25.82%
sales general and administrative to revenue
4.57
-
1.64
-
4.54
176.25%
1.05
76.84%
0.55
47.52%
shareholders equity per share
1.80
-
2.80
55.69%
5.02
79.51%
3.63
27.71%
4.22
16.34%
5.33
26.17%
6.95
30.45%
12.10
73.98%
14.52
20.07%
17.83
22.74%
22.85
28.15%
stock based compensation to revenue
2.34
-
1.44
-
1.90
32.13%
0.26
86.14%
0.13
51.09%
0.10
25.79%
0.10
0.12%
0.12
23.83%
0.12
1.79%
0.10
11.45%
tangible asset value
120.41M
-
208.70M
73.32%
424.45M
103.38%
314.88M
25.82%
372.14M
18.19%
480.76M
29.19%
636.90M
32.48%
1.13B
76.83%
1.37B
22.00%
1.67B
21.59%
2.20B
31.48%
tangible book value per share
1.80
-
2.80
55.69%
5.02
79.51%
3.63
27.71%
4.22
16.34%
5.33
26.17%
6.95
30.45%
12.10
73.98%
14.52
20.07%
17.44
20.06%
22.48
28.92%
working capital
136.76M
-
182.54M
33.47%
358.36M
96.32%
280.03M
21.86%
500.49M
78.73%
649.54M
29.78%
265.70M
59.09%
829.70M
212.27%
727M
12.38%
915.80M
25.97%
952.20M
3.97%

All numbers in USD (except ratios and percentages)